Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-03
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 140
- Registration Number
- NCT00468871
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 239
- Registration Number
- NCT00456482
Zylet vs TobraDex in Blepharokeratoconjunctivitis
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-03-14
- Last Posted Date
- 2011-12-09
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 276
- Registration Number
- NCT00447577
- Locations
- 🇺🇸
Cornerstone Eye Care, High Point, North Carolina, United States
Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma
- First Posted Date
- 2007-03-01
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 176
- Registration Number
- NCT00441883
- Locations
- 🇺🇸
Pfizer Investigational Site, Austin, Texas, United States
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-01-19
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 107
- Registration Number
- NCT00424398
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 90
- Registration Number
- NCT00423007
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Pediatric Zylet Safety and Efficacy Study
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 108
- Registration Number
- NCT00420628
- Locations
- 🇺🇸
Pediatric Ophthalmology of Erie, Erie, Pennsylvania, United States
Systemic Pharmacokinetics of BOL-303224-A
- First Posted Date
- 2006-12-05
- Last Posted Date
- 2011-12-09
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 24
- Registration Number
- NCT00407589
- Locations
- 🇺🇸
Cornerstone Eyecare, High point, North Carolina, United States
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 278
- Registration Number
- NCT00407082
- Locations
- 🇺🇸
Duke Eye Center, Durham, North Carolina, United States
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2015-02-20
- Lead Sponsor
- Bausch & Lomb Incorporated
- Registration Number
- NCT00375596
© Copyright 2024. All Rights Reserved by MedPath